Peripheral Vascular Devices Market Size, Share, Analysis Report

Peripheral Vascular Devices Market Size by Product (EVAR Stent Grafts, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Other Devices), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast

The global peripheral vascular devices market is expected to be around US$ 14.50 billion by 2028 at a CAGR of 6.5% during the forecast period.

Purchase User License

MARKET SNAPSHOT

Major Players

  • Endocore GmbH
  • Andramed GmbH
  • AMG International
  • Vascular Concept
  • Pan Med
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    6

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    Peripheral vascular disease may be contraction of arteries outside the brain and heart. Risk factors for the development of PVD contain hypertension, obesity, diabetes and smoking. More than 5% of the population above the age of 50 years smarts from PVD. Insufficient blood flow and narrowing of routes are the most common peripheral diseases caused owing to plaque buildup. The North American region accounts for the main market share. Asia-Pacific is the fastest increasing market, on account of favorable demographic and economic conditions. The main segments in the market contain peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic defense devices and inferior vena cava filters. Embolic protection devices are the wildest rising segment in the total peripheral vascular devices market. Development of the global peripheral vascular devices market is fueled by the rate of population growth globally and the high frequency of peripheral vascular diseases owing to growing aging population. Increasing healthcare awareness and growing disposable incomes are other important factors driving the growth of the market.

    The global peripheral vascular devices market is expected to be around US$ 14.50 billion by 2028  at a CAGR of 6.5% during the forecast period.

    The global Peripheral Vascular Devices market is segregated on the basis of Product as EVAR Stent Grafts, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, and Other Devices.

    The global Peripheral Vascular Devices market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Peripheral Vascular Devices market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

    Competitive Rivalry

    Endocore GmbH, Andramed GmbH, AMG International, Vascular Concept, Pan Med, Medtronic, Boston Scientific Corporation, Abbott Laboratories, Becton, Dickinson and Company, Terumo Corporation, and others are among the major players in the global Peripheral Vascular Devices market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

    The Peripheral Vascular Devices Market has been segmented as below:

    Peripheral Vascular Devices Market, By Product

    • EVAR Stent Grafts
    • Inferior Vena Cava Filters
    • Hemodynamic Flow Alteration Devices
    • Angioplasty Balloons
    • Angioplasty Stents
    • Catheters
    • Plaque Modification Devices
    • Other Devices

    Peripheral Vascular Devices Market, By Region

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Peripheral Vascular Devices Market, By Company

    • Endocore GmbH
    • Andramed GmbH
    • AMG International
    • Vascular Concept
    • Pan Med
    • Medtronic
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Terumo Corporation
    • Cordis
    • B. Braun Melsungen AG
    • Ivascular
    • Biosensors International Group Ltd.
    • Biotronik
    • Penumbra, Inc.
    • W.L. Gore & Associates
    • Merit Medical Systems
    • Cook
    • Spectranetics Corporation

    The report covers:

    • Global Peripheral Vascular Devices market sizes from 2021 to 2028, along with CAGR for 2023-2028
    • Market size comparison for 2022 vs 2028 with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
    • Global Peripheral Vascular Devices market trends, covering comprehensive range of consumer trends & manufacturer trends
    • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Peripheral Vascular Devices market
    • Major market opportunities and challenges in forecast timeframe to be focused
    • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
    • Comprehensive company profiles of the key industry players

    Report Scope:

    The global Peripheral Vascular Devices market report scope includes detailed study covering underlying factors influencing the industry trends.

    The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

    The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Peripheral Vascular Devices market share. Major industry players with significant revenue share include Endocore GmbH, Andramed GmbH, AMG International, Vascular Concept, Pan Med, Medtronic, Boston Scientific Corporation, Abbott Laboratories, Becton, Dickinson and Company, Terumo Corporation, and others.

    Reasons to Buy this Report:

    • Gain detailed insights on the Peripheral Vascular Devices industry trends
    • Find complete analysis on the market status
    • Identify the Peripheral Vascular Devices market opportunities and growth segments
    • Analyse competitive dynamics by evaluating business segments & product portfolios
    • Facilitate strategy planning and industry dynamics to enhance decision making

    Some of the recent developments in Peripheral Vascular Devices Market are as follows:

    Medtronic

    • 07-2020: Medtronic plc and Tandem Diabetes Care, Inc. declared that they have entered into a non-exclusive patent cross-license agreement for certain technologies in the field of diabetes.
    • 07-2020: Medtronic plc is a global leader in medical technology, declared the start of a prospective, observational, global, multi-center, real-world, post-market study to estimate the safety and effectiveness of the Valiant Navion™ Thoracic Stent Graft System in the treatment of thoracic aortic dissection.

    B. Braun Melsungen AG

    • 05-2018: B. Braun Medical Inc. will cabinet its portfolio of innovative products that support successful peripheral intravenous (PIV) access in booth at the Infusion Nurses Society Annual Meeting.

    Customization

    Customized report as per the requirement can be offered with appropriate recommendations

    Below are our new reports:

    Digital MRO Market

    Patch Based Wound Healing Product Market

    Orthopedic Clinics Braces and Support Casting and Splints Market

    Hospital Braces and Support Casting and Splints Market

    OTC Casting and Splinting Products Market

    1. Introduction
        1.1 Key Insights
        1.2 Report Overview
        1.3 Markets Covered
        1.4 Stakeholders
    2. Research Methodology
        2.1 Research Scope
        2.2 Market Research Process
        2.3 Research Data Analysis
            2.4.1 Secondary Research
            2.4.2 Primary Research
            2.4.3 Models for Estimation
        2.5 Market Size Estimation
            2.5.1 Bottom-Up Approach – Segmental Market Analysis
            2.5.2 Top-Down Approach – Parent Market Analysis
    3. Executive Summary
    4. Market Overview
        4.1 Introduction
            4.2.1 Drivers
            4.2.2 Restraints
            4.2.3 Opportunities
            4.2.4 Challenges
        4.2 Porter’s Five Force Analysis
    5. Peripheral Vascular Devices Market, By Product
        5.1 Introduction
        5.2 EVAR Stent Grafts
            5.2.1 Market Overview
            5.2.2 Market Size and Forecast
        5.3 Inferior Vena Cava Filters
            5.3.1 Market Overview
            5.3.2 Market Size and Forecast
        5.4 Hemodynamic Flow Alteration Devices
            5.4.1 Market Overview
            5.4.2 Market Size and Forecast
        5.5 Angioplasty Balloons
            5.5.1 Market Overview
            5.5.2 Market Size and Forecast
        5.6 Angioplasty Stents
            5.6.1 Market Overview
            5.6.2 Market Size and Forecast
        5.7 Catheters
            5.7.1 Market Overview
            5.7.2 Market Size and Forecast
        5.8 Plaque Modification Devices
            5.8.1 Market Overview
            5.8.2 Market Size and Forecast
        5.9 Other Devices
            5.9.1 Market Overview
            5.9.2 Market Size and Forecast
    6. Peripheral Vascular Devices Market, By Geography
        6.1 Introduction
        6.2 North America
            6.2.1 North America Peripheral Vascular Devices, By Product
        6.3 Europe
            6.3.1 Europe Peripheral Vascular Devices, By Product
        6.4 Asia-Pacific
            6.4.1 Asia-Pacific Peripheral Vascular Devices, By Product
        6.5 Rest of the World
            6.5.1 Rest of the World Peripheral Vascular Devices, By Product
    7. Competitive Insights
        7.1 Key Insights
        7.2 Company Market Share Analysis
        7.3 Strategic Outlook
            7.3.1 Mergers & Acquisitions
            7.3.2 New Product Development
            7.3.3 Portfolio/Production Capacity Expansions
            7.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
            7.3.5 Others
    8. Company Profiles
        8.1 Endocore GmbH
            8.1.1 Company Overview
            8.1.2 Product/Service Landscape
            8.1.3 Financial Overview
            8.1.4 Recent Developments
        8.2 Andramed GmbH
            8.2.1 Company Overview
            8.2.2 Product/Service Landscape
            8.2.3 Financial Overview
            8.2.4 Recent Developments
        8.3 AMG International
            8.3.1 Company Overview
            8.3.2 Product/Service Landscape
            8.3.3 Financial Overview
            8.3.4 Recent Developments
        8.4 Vascular Concept
            8.4.1 Company Overview
            8.4.2 Product/Service Landscape
            8.4.3 Financial Overview
            8.4.4 Recent Developments
        8.5 Pan Med
            8.5.1 Company Overview
            8.5.2 Product/Service Landscape
            8.5.3 Financial Overview
            8.5.4 Recent Developments
        8.6 Medtronic
            8.6.1 Company Overview
            8.6.2 Product/Service Landscape
            8.6.3 Financial Overview
            8.6.4 Recent Developments
        8.7 Boston Scientific Corporation
            8.7.1 Company Overview
            8.7.2 Product/Service Landscape
            8.7.3 Financial Overview
            8.7.4 Recent Developments
        8.8 Abbott Laboratories
            8.8.1 Company Overview
            8.8.2 Product/Service Landscape
            8.8.3 Financial Overview
            8.8.4 Recent Developments
        8.9 Becton, Dickinson and Company
            8.9.1 Company Overview
            8.9.2 Product/Service Landscape
            8.9.3 Financial Overview
            8.9.4 Recent Developments
        8.10 Terumo Corporation
            8.10.1 Company Overview
            8.10.2 Product/Service Landscape
            8.10.3 Financial Overview
            8.10.4 Recent Developments
                8.11 Cordis
                           8.11.1 Company Overview
            8.11.2 Product/Service Landscape
            8.11.3 Financial Overview
            8.11.4 Recent Developments
                  8.12 B. Braun Melsungen AG
                           8.12.1 Company Overview
            8.12.2 Product/Service Landscape
            8.12.3 Financial Overview
            8.12.4 Recent Developments
                  8.13 Ivascular
                            8.13.1 Company Overview
            8.13.2 Product/Service Landscape
            8.13.3 Financial Overview
            8.13.4 Recent Developments
                   8.14 Biosensors International Group Ltd.
                            8.14.1 Company Overview
            8.14.2 Product/Service Landscape
            8.14.3 Financial Overview
            8.14.4 Recent Developments
               8.15 Biotronik
                            8.15.1 Company Overview
            8.15.2 Product/Service Landscape
            8.15.3 Financial Overview
            8.15.4 Recent Developments
                 8.16 Penumbra, Inc
                            8.16.1 Company Overview
            8.16.2 Product/Service Landscape
            8.16.3 Financial Overview
            8.16.4 Recent Developments
                 8.17 W.L. Gore & Associates
                            8.17.1 Company Overview
            8.17.2 Product/Service Landscape
            8.17.3 Financial Overview
            8.17.4 Recent Developments
                  8.18 Merit Medical Systems
                            8.18.1 Company Overview
            8.18.2 Product/Service Landscape
            8.18.3 Financial Overview
            8.18.4 Recent Developments
                   8.19 Cook
                            8.19.1 Company Overview
            8.19.2 Product/Service Landscape
            8.19.3 Financial Overview
            8.19.4 Recent Developments
                8.20 Spectranetics Corporation
                           8.20.1 Company Overview
            8.20.2 Product/Service Landscape
            8.20.3 Financial Overview
            8.20.4 Recent Developments

    The Peripheral Vascular Devices Market has been segmented as below:

    Peripheral Vascular Devices Market, By Product

    • EVAR Stent Grafts
    • Inferior Vena Cava Filters
    • Hemodynamic Flow Alteration Devices
    • Angioplasty Balloons
    • Angioplasty Stents
    • Catheters
    • Plaque Modification Devices
    • Other Devices

    Peripheral Vascular Devices Market, By Region

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Peripheral Vascular Devices Market, By Company

    • Endocore GmbH
    • Andramed GmbH
    • AMG International
    • Vascular Concept
    • Pan Med
    • Medtronic
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Terumo Corporation
    • Cordis
    • B. Braun Melsungen AG
    • Ivascular
    • Biosensors International Group Ltd.
    • Biotronik
    • Penumbra, Inc.
    • W.L. Gore & Associates
    • Merit Medical Systems
    • Cook
    • Spectranetics Corporation

    Got a question? We've got answers. If you have some other questions, see our support center.

    The market is expected to grow at a CAGR of 6.5% during the study period (2023-2028)
    The global peripheral vascular devices market is expected to be around US$ 14.50 billion by 2028
    The segment included in Peripheral Vascular Devices market is Product, Company and region.
    Some key players operating in the Peripheral Vascular Devices market include Endocore GmbH, Andramed GmbH, AMG International, Vascular Concept, Pan Med, Medtronic, Boston Scientific Corporation, Abbott Laboratories
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports